Adding Diverse Noncanonical Backbones to Rosetta: Enabling Peptidomimetic Design

作者：Drew Kevin; Renfrew P Douglas; Craven Timothy W; Butterfoss Glenn L; Chou Fang Chieh; Lyskov Sergey; Bullock Brooke N; Watkins Andrew; Labonte Jason W; Pacella Michael; Kilambi Krishna Praneeth; Leaver Fay Andrew; Kuhlman Brian; Gray Jeffrey J; Bradley Philip; Kirshenbaum Kent; Arora Paramjit S; Das Rhiju; Bonneau Richard^*

来源：PLos One, 2013, 8(7): e67051.

DOI：10.1371/journal.pone.0067051

Peptidomimetics are classes of molecules that mimic structural and functional attributes of polypeptides. Peptidomimetic oligomers can frequently be synthesized using efficient solid phase synthesis procedures similar to peptide synthesis. Conformationally ordered peptidomimetic oligomers are finding broad applications for molecular recognition and for inhibiting protein-protein interactions. One critical limitation is the limited set of design tools for identifying oligomer sequences that can adopt desired conformations. Here, we present expansions to the ROSETTA platform that enable structure prediction and design of five non-peptidic oligomer scaffolds (noncanonical backbones), oligooxopiperazines, oligo-peptoids, beta-peptides, hydrogen bond surrogate helices and oligosaccharides. This work is complementary to prior additions to model noncanonical protein side chains in ROSETTA. The main purpose of our manuscript is to give a detailed description to current and future developers of how each of these noncanonical backbones was implemented. Furthermore, we provide a general outline for implementation of new backbone types not discussed here. To illustrate the utility of this approach, we describe the first tests of the ROSETTA molecular mechanics energy function in the context of oligooxopiperazines, using quantum mechanical calculations as comparison points, scanning through backbone and side chain torsion angles for a model peptidomimetic. Finally, as an example of a novel design application, we describe the automated design of an oligooxopiperazine that inhibits the p53-MDM2 protein-protein interaction. For the general biological and bioengineering community, several noncanonical backbones have been incorporated into web applications that allow users to freely and rapidly test the presented protocols (http://rosie.rosettacommons.org). This work helps address the peptidomimetic community's need for an automated and expandable modeling tool for noncanonical backbones.

• 出版日期2013-7-15